Ankur Drugs And Pharma Profile
Key Indicators
- Authorised Capital ₹ 28.00 Cr
- Paid Up Capital ₹ 19.34 Cr
- Company Age 30 Year, 17 Days
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 2,253.69 Cr
About Ankur Drugs And Pharma
Ankur Drugs And Pharma Limited (ADAPL) is Under Liquidation company established on 09 Feb 1995 with its office registered at Mumbai, Maharashtra, India and has been running since 30 Year, 17 Days with a paid up capital of 19.34 Cr. According to MCA records, 4 Directors and 1 Signatories are linked to this company as of 04 Nov 2024.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24230MH1995PLC085410
- Company No.
085410
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 Feb 1995
- Date of AGM
30 Sep 2011
- Date of Balance Sheet
31 Mar 2011
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Ankur Drugs And Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Rane  | Company Secretary | 01-Aug-2005 | Current |
| Purnandu Jain | Managing Director | 15-Oct-1996 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girraj Vijayvargiya | Whole-Time Director | 02-Apr-2006 | Current |
| Dileep Shinde | Director | 31-Aug-2004 | Current |
| Ramesh Batham | Director | 14-Oct-2010 | Current |
Financial Performance of Ankur Drugs And Pharma.
Enhance accessibility to Ankur Drugs And Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ankur Drugs And Pharma?
Unlock access to Ankur Drugs And Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Balkrishna Paper Mills LimitedDileep Shinde is a mutual person
Kores (India) LimitedSanjay Rane is a mutual person
Charges (Loans)
Open Charges
₹2,253.69 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 791.95 Cr
- Punjab National Bank : 190.82 Cr
- Central Bank Of India : 170.00 Cr
- Syndicate Bank : 165.25 Cr
- State Bank Of Indore : 128.74 Cr
- Others : 806.93 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2012 | Ifci Factors Limited | ₹5.00 Cr | Open |
| 13 Jul 2011 | The Shamrao Vithal Co-Operative Bank Limited | ₹8.85 Cr | Open |
| 09 Jun 2011 | Indusind Bank Ltd. | ₹8.00 Cr | Open |
| 10 Feb 2011 | The Shamrao Vithal Co-Operative Bank Ltd. | ₹3.50 Cr | Open |
| 17 Jan 2011 | Ifci Factors Limited | ₹15.00 Cr | Open |
How Many Employees Work at Ankur Drugs And Pharma?
Ankur Drugs And Pharma has a workforce of 101 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ankur Drugs And Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ankur Drugs And Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
